Eliminate the manual, risk-prone process of CMC content authoring.

The drug manufacturing process involves a vast amount of documentation across many regions. Using desktop software to manually create and update these complex documents can result in tremendous inefficiencies and irrelevant or inaccurate information. Because all stages of the drug development life cycle involve chemistry manufacturing and controls content, it’s critical that documentation is accurate, globally-relevant and expeditious.

A professional woman in a white blazer typing on a keyboard at her desk, symbolizing the process of creating or managing CMC documentation in a structured office environment.

A single platform to increase speed and efficiency of document development.

Close-up of a hand holding a pen and reviewing documents on a desk, symbolizing the detailed review and preparation of Pharma SOP and CMC documentation in a professional setting.

Docuvera’s component authoring solution improves documentation efficiency and content accuracy by reusing approved, compliant blocks of content to build and update CMC documents. As a single platform to author, review, approve, translate, reuse and publish CMC documents, Docuvera enables the reuse of core, global information to assemble regional documentation. By referencing one global, single-source of content, the risk of using inaccurate documentation is avoided, while the speed and efficiency of document development is vastly increased.